Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Solvonis Therapeutics PLC

SVNS.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Biotechnology & Medical Research ·

UK Micro Cap Analyst: BUY

Last Close

$0.00

▲ +0.00%

Market Cap $13.77M · Vol 58.32M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$13.77M

Micro Cap

Div Yield

N/A

EPS Growth

+31.33%

YoY

RSI (14)

43.53

Momentum

Beta

1.20

vs Market

52W High

$0.01

62.20% below

52W Low

$0.00

25.76% above

Volume

58.32M

Avg 30.63M

P/B

3.41

Price-to-book

ROE

N/A

Return on equity

Free Float

62.52%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Solvonis Therapeutics PLC (SVNS.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SVNS.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-11.76%

-33.33%

-42.31%

YTD

-51.61%

-93.20%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-7,733,452.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-106.41% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	3.41
P/FCF	N/A
EPS Growth	+31.33%
Outstanding Shares	6.81B

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.00
RSI (14)	43.53
Beta	1.20
52-Week High	$0.01
52-Week Low	$0.00

Volume Today	58.32M
Avg Daily Volume (30D)	30.63M
Relative Volume	1.90x
Volatility (10D)	98.16
Volatility (30D)	86.59
Free Float	62.52%

Analyst Consensus

BUY

Current Price $0.00

Mean Target $0.02

52W Low$0.00 52W High$0.01

Current

Target

$0.00 $0.01

Current Analyst target

+1,034.09% upside potential · 2 analysts

Identifiers

ExchangeLSE

FIGIBBG0147DYM99

ISINGB00BMD1Z199

CountryUnited Kingdom

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Solvonis Therapeutics PLC is a clinical-stage biotechnology company developing treatments for addiction and mental health disorders. The Company is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. It is focused on Alcohol Use Disorder (AUD), which affects over 40 million people across the United States, United Kingdom, and EU4 markets, and Post-Traumatic Stress Disorder (PTSD), impacting more than 13 million adults in the United States and approximately 20 million across those same regions. AUD is characterized by compulsive, harmful drinking, and is associated with significant health risks, including chronic diseases, mental health conditions and accidents, injuries and violence. PTSD is a complex and debilitating mental health condition that develops in some people who have experienced traumatic events, for example violence, an accident, war or a natural disaster.